Catalyst Wire Dossier Catalyst Wire Dossier

Trikafta (elexacaftor/tezacaftor/ivacaftor)

elexacaftor/tezacaftor/ivacaftor · Vertex Pharmaceuticals
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Trikafta (elexacaftor/tezacaftor/ivacaftor), covering 2023-10-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older [Phase 3]

See pricing